eduKateSG · Why Science?
Learn from healthcare that already happened while protecting the research question from selection, measurement error, confounding and invisible changes in data systems
Read FDA’s final March 2026 ICH M14 guidance through research questions, target populations, data-source fitness, exposure, outcomes, covariates, design, bias, confounding, missing data, analysis, sensitivity, transparency, reporting and submission.
Healthcare systems create records while caring for people: prescriptions, diagnoses, laboratory results, procedures, admissions and follow-up. Non-interventional studies can use those real-world data to investigate medicine safety without assigning treatment.
FDA lists ICH M14 as final Level 1 Guidance dated March 2026. It replaces the July 2024 draft and FDA also withdrew its May 2013 guidance on best practices for electronic healthcare-data safety studies.
Did you know? M14 focuses on safety assessment, yet FDA states that its principles are also applicable to non-interventional studies of effectiveness. The central discipline is the same: define the question before adapting it to convenient data.
For students, M14 is modern detective work. Every code and date is a clue, but the study becomes science only when provenance, selection, time, missingness and alternative explanations remain visible.
Chapter index
Chapters 1–9: March 2026 final M14, non-interventional RWD studies
- 1. M14 covers non-interventional studies using real-world data
- 2. FDA lists M14 as final Level 1 Guidance from March 2026
- 3. A precise research question anchors every later choice
- 4. The target trial idea can clarify causal questions
- 5. Data-source fitness is question specific
- 6. Provenance reveals how care became a research variable
- 7. Exposure definitions need start, stop and adherence logic
- 8. Comparator choice shapes confounding and interpretation
- 9. Outcome validation protects against code-only assumptions
Chapters 10–17: research question, data fitness, exposure, outcomes, confounding, bias, analysis, sensitivity and reporting
- 10. Covariates should capture causes of treatment and outcome
- 11. Design choices can control bias before modelling
- 12. Confounding methods require overlap and diagnostics
- 13. Missing data need a mechanism and sensitivity plan
- 14. Measurement error can affect exposure, outcome and covariates
- 15. The analysis plan should precede outcome-driven choices
- 16. Sensitivity analyses test rival explanations
- 17. A complete M14 receipt makes the study auditable
CHAPTER 1 OF 17 · Frame the safety question
1. M14 covers non-interventional studies using real-world data
The guidance outlines general principles for planning, designing, analysing and reporting studies that assess medicine safety without protocol-assigned treatment. Drugs, vaccines and other biological products fall within its stated medicine scope.
The scientific value of m14 covers non-interventional studies using real-world data appears when evidence is connected to a defined decision. The guidance outlines general principles for planning, designing, analysing and reporting studies that assess medicine safety without protocol-assigned treatment. Drugs, vaccines and other biological products fall within its stated medicine scope. Keep this boundary visible: Real-world data record healthcare processes as well as health, and those processes can change over time.
Try this
Build an evidence map for m14 covers non-interventional studies using real-world data. Write the population, exposure, comparator, outcome and time frame for m14 covers non-interventional studies using real-world data before inspecting results. Add the decision, owner and acceptance criterion. Keep this limit: Real-world data record healthcare processes as well as health, and those processes can change over time.
A strong science note separates observation from interpretation. Write the population, exposure, comparator, outcome and time frame for m14 covers non-interventional studies using real-world data before inspecting results. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Write the population, exposure, comparator, outcome and time frame for m14 covers non-interventional studies using real-world data before inspecting results. Keep this boundary visible: Real-world data record healthcare processes as well as health, and those processes can change over time.
CHAPTER 2 OF 17 · Frame the safety question
2. FDA lists M14 as final Level 1 Guidance from March 2026
The final replaces the July 2024 draft. FDA states that the recommendations complement its other real-world-evidence guidances and withdrew the May 2013 electronic-healthcare-data safety-study guidance.
For fda lists m14 as final level 1 guidance from march 2026, a useful explanation shows the data, assumptions and operational response together. The final replaces the July 2024 draft. FDA states that the recommendations complement its other real-world-evidence guidances and withdrew the May 2013 electronic-healthcare-data safety-study guidance. Preserve this guardrail: Adjustment controls measured confounders only to the extent that variables are valid and models have support.
Try this
Challenge the assumptions behind fda lists m14 as final level 1 guidance from march 2026. Trace every variable in fda lists m14 as final level 1 guidance from march 2026 to its operational source and validation evidence. Test a plausible failure mode and record the result. Respect this boundary: Adjustment controls measured confounders only to the extent that variables are valid and models have support.
A strong science note separates observation from interpretation. Trace every variable in fda lists m14 as final level 1 guidance from march 2026 to its operational source and validation evidence. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Trace every variable in fda lists m14 as final level 1 guidance from march 2026 to its operational source and validation evidence. Keep this boundary visible: Adjustment controls measured confounders only to the extent that variables are valid and models have support.
CHAPTER 3 OF 17 · Frame the safety question
3. A precise research question anchors every later choice
Population, exposure, comparator, outcome, time horizon and causal or descriptive objective are stated before data analysis. A protocol explains the regulatory or safety decision the study is meant to inform.
A trustworthy account of a precise research question anchors every later choice keeps the protocol, implementation and lifecycle record aligned. Population, exposure, comparator, outcome, time horizon and causal or descriptive objective are stated before data analysis. A protocol explains the regulatory or safety decision the study is meant to inform. Remember: A diagnosis code can be a useful signal without being a perfectly timed or confirmed clinical event.
Try this
Audit the lifecycle record for a precise research question anchors every later choice. Challenge a precise research question anchors every later choice with a negative control, alternate definition or quantitative bias analysis. Mark what changed, why it changed and what evidence closed the question. Preserve this caution: A diagnosis code can be a useful signal without being a perfectly timed or confirmed clinical event.
A strong science note separates observation from interpretation. Challenge a precise research question anchors every later choice with a negative control, alternate definition or quantitative bias analysis. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Challenge a precise research question anchors every later choice with a negative control, alternate definition or quantitative bias analysis. Keep this boundary visible: A diagnosis code can be a useful signal without being a perfectly timed or confirmed clinical event.
CHAPTER 4 OF 17 · Frame the safety question
4. The target trial idea can clarify causal questions
Eligibility, treatment strategies, assignment, follow-up, outcome, causal contrast and analysis can be described as if a pragmatic trial were being emulated. The observational implementation then identifies where real-world data depart from that ideal.
The scientific value of the target trial idea can clarify causal questions appears when evidence is connected to a defined decision. Eligibility, treatment strategies, assignment, follow-up, outcome, causal contrast and analysis can be described as if a pragmatic trial were being emulated. The observational implementation then identifies where real-world data depart from that ideal. Keep this boundary visible: A protocol written after results are known cannot provide the same protection against outcome-driven choices.
Try this
Build an evidence map for the target trial idea can clarify causal questions. Reproduce the target trial idea can clarify causal questions from versioned data, code, cohort flow and decision logs. Add the decision, owner and acceptance criterion. Keep this limit: A protocol written after results are known cannot provide the same protection against outcome-driven choices.
A strong science note separates observation from interpretation. Reproduce the target trial idea can clarify causal questions from versioned data, code, cohort flow and decision logs. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Reproduce the target trial idea can clarify causal questions from versioned data, code, cohort flow and decision logs. Keep this boundary visible: A protocol written after results are known cannot provide the same protection against outcome-driven choices.
Claims, electronic health records, registries, dispensing data or linked sources differ in population coverage, clinical detail, continuity and timeliness. A famous database is not automatically suitable for a particular exposure, outcome or follow-up period.
For data-source fitness is question specific, a useful explanation shows the data, assumptions and operational response together. Claims, electronic health records, registries, dispensing data or linked sources differ in population coverage, clinical detail, continuity and timeliness. A famous database is not automatically suitable for a particular exposure, outcome or follow-up period. Preserve this guardrail: Real-world data record healthcare processes as well as health, and those processes can change over time.
Try this
Challenge the assumptions behind data-source fitness is question specific. Write the population, exposure, comparator, outcome and time frame for data-source fitness is question specific before inspecting results. Test a plausible failure mode and record the result. Respect this boundary: Real-world data record healthcare processes as well as health, and those processes can change over time.
A strong science note separates observation from interpretation. Write the population, exposure, comparator, outcome and time frame for data-source fitness is question specific before inspecting results. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Write the population, exposure, comparator, outcome and time frame for data-source fitness is question specific before inspecting results. Keep this boundary visible: Real-world data record healthcare processes as well as health, and those processes can change over time.
CHAPTER 6 OF 17 · Choose fit data
6. Provenance reveals how care became a research variable
The study traces why a field was created, who recorded it, coding systems, transformation, linkage and refresh history. Changes in reimbursement, clinical practice or software can create apparent trends unrelated to biology.
A trustworthy account of provenance reveals how care became a research variable keeps the protocol, implementation and lifecycle record aligned. The study traces why a field was created, who recorded it, coding systems, transformation, linkage and refresh history. Changes in reimbursement, clinical practice or software can create apparent trends unrelated to biology. Remember: Adjustment controls measured confounders only to the extent that variables are valid and models have support.
Try this
Audit the lifecycle record for provenance reveals how care became a research variable. Trace every variable in provenance reveals how care became a research variable to its operational source and validation evidence. Mark what changed, why it changed and what evidence closed the question. Preserve this caution: Adjustment controls measured confounders only to the extent that variables are valid and models have support.
A strong science note separates observation from interpretation. Trace every variable in provenance reveals how care became a research variable to its operational source and validation evidence. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Trace every variable in provenance reveals how care became a research variable to its operational source and validation evidence. Keep this boundary visible: Adjustment controls measured confounders only to the extent that variables are valid and models have support.
CHAPTER 7 OF 17 · Choose fit data
7. Exposure definitions need start, stop and adherence logic
Prescription, dispensing, administration and self-report measure different events. Grace periods, stockpiling, switching, discontinuation and dose changes affect exposed person-time. Immortal time can appear when classification uses future information.
The scientific value of exposure definitions need start, stop and adherence logic appears when evidence is connected to a defined decision. Prescription, dispensing, administration and self-report measure different events. Grace periods, stockpiling, switching, discontinuation and dose changes affect exposed person-time. Immortal time can appear when classification uses future information. Keep this boundary visible: A diagnosis code can be a useful signal without being a perfectly timed or confirmed clinical event.
Try this
Build an evidence map for exposure definitions need start, stop and adherence logic. Challenge exposure definitions need start, stop and adherence logic with a negative control, alternate definition or quantitative bias analysis. Add the decision, owner and acceptance criterion. Keep this limit: A diagnosis code can be a useful signal without being a perfectly timed or confirmed clinical event.
A strong science note separates observation from interpretation. Challenge exposure definitions need start, stop and adherence logic with a negative control, alternate definition or quantitative bias analysis. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Challenge exposure definitions need start, stop and adherence logic with a negative control, alternate definition or quantitative bias analysis. Keep this boundary visible: A diagnosis code can be a useful signal without being a perfectly timed or confirmed clinical event.
CHAPTER 8 OF 17 · Choose fit data
8. Comparator choice shapes confounding and interpretation
Active comparators with similar indications can improve clinical comparability. Non-users or historical controls may differ in healthcare contact and disease severity. The index date and eligibility rules should be applied symmetrically.
For comparator choice shapes confounding and interpretation, a useful explanation shows the data, assumptions and operational response together. Active comparators with similar indications can improve clinical comparability. Non-users or historical controls may differ in healthcare contact and disease severity. The index date and eligibility rules should be applied symmetrically. Preserve this guardrail: A protocol written after results are known cannot provide the same protection against outcome-driven choices.
Try this
Challenge the assumptions behind comparator choice shapes confounding and interpretation. Reproduce comparator choice shapes confounding and interpretation from versioned data, code, cohort flow and decision logs. Test a plausible failure mode and record the result. Respect this boundary: A protocol written after results are known cannot provide the same protection against outcome-driven choices.
A strong science note separates observation from interpretation. Reproduce comparator choice shapes confounding and interpretation from versioned data, code, cohort flow and decision logs. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Reproduce comparator choice shapes confounding and interpretation from versioned data, code, cohort flow and decision logs. Keep this boundary visible: A protocol written after results are known cannot provide the same protection against outcome-driven choices.
CHAPTER 9 OF 17 · Design for bias control
9. Outcome validation protects against code-only assumptions
Diagnosis codes, procedures, laboratory thresholds, algorithms or adjudication can identify outcomes. Positive predictive value, sensitivity, severity and timing matter. A valid algorithm in one system or era may not transfer unchanged.
A trustworthy account of outcome validation protects against code-only assumptions keeps the protocol, implementation and lifecycle record aligned. Diagnosis codes, procedures, laboratory thresholds, algorithms or adjudication can identify outcomes. Positive predictive value, sensitivity, severity and timing matter. A valid algorithm in one system or era may not transfer unchanged. Remember: Real-world data record healthcare processes as well as health, and those processes can change over time.
Try this
Audit the lifecycle record for outcome validation protects against code-only assumptions. Write the population, exposure, comparator, outcome and time frame for outcome validation protects against code-only assumptions before inspecting results. Mark what changed, why it changed and what evidence closed the question. Preserve this caution: Real-world data record healthcare processes as well as health, and those processes can change over time.
A strong science note separates observation from interpretation. Write the population, exposure, comparator, outcome and time frame for outcome validation protects against code-only assumptions before inspecting results. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Write the population, exposure, comparator, outcome and time frame for outcome validation protects against code-only assumptions before inspecting results. Keep this boundary visible: Real-world data record healthcare processes as well as health, and those processes can change over time.
CHAPTER 10 OF 17 · Design for bias control
10. Covariates should capture causes of treatment and outcome
Demographics, disease severity, comorbidities, prior treatment, healthcare utilisation and calendar time can reduce confounding when measured before exposure. Variables affected by treatment or selected after index can introduce bias.
The scientific value of covariates should capture causes of treatment and outcome appears when evidence is connected to a defined decision. Demographics, disease severity, comorbidities, prior treatment, healthcare utilisation and calendar time can reduce confounding when measured before exposure. Variables affected by treatment or selected after index can introduce bias. Keep this boundary visible: Adjustment controls measured confounders only to the extent that variables are valid and models have support.
Try this
Build an evidence map for covariates should capture causes of treatment and outcome. Trace every variable in covariates should capture causes of treatment and outcome to its operational source and validation evidence. Add the decision, owner and acceptance criterion. Keep this limit: Adjustment controls measured confounders only to the extent that variables are valid and models have support.
A strong science note separates observation from interpretation. Trace every variable in covariates should capture causes of treatment and outcome to its operational source and validation evidence. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Trace every variable in covariates should capture causes of treatment and outcome to its operational source and validation evidence. Keep this boundary visible: Adjustment controls measured confounders only to the extent that variables are valid and models have support.
CHAPTER 11 OF 17 · Design for bias control
11. Design choices can control bias before modelling
New-user cohorts, active comparators, restriction, matching, washout and appropriate time zero help align groups. Case-control, self-controlled and other designs answer different questions and rely on different assumptions.
For design choices can control bias before modelling, a useful explanation shows the data, assumptions and operational response together. New-user cohorts, active comparators, restriction, matching, washout and appropriate time zero help align groups. Case-control, self-controlled and other designs answer different questions and rely on different assumptions. Preserve this guardrail: A diagnosis code can be a useful signal without being a perfectly timed or confirmed clinical event.
Try this
Challenge the assumptions behind design choices can control bias before modelling. Challenge design choices can control bias before modelling with a negative control, alternate definition or quantitative bias analysis. Test a plausible failure mode and record the result. Respect this boundary: A diagnosis code can be a useful signal without being a perfectly timed or confirmed clinical event.
A strong science note separates observation from interpretation. Challenge design choices can control bias before modelling with a negative control, alternate definition or quantitative bias analysis. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Challenge design choices can control bias before modelling with a negative control, alternate definition or quantitative bias analysis. Keep this boundary visible: A diagnosis code can be a useful signal without being a perfectly timed or confirmed clinical event.
CHAPTER 12 OF 17 · Design for bias control
12. Confounding methods require overlap and diagnostics
Stratification, regression, propensity scores, weighting or matching adjust measured differences. Balance, positivity, extreme weights and model specification are examined. No technique removes unmeasured confounding merely because software produces an estimate.
A trustworthy account of confounding methods require overlap and diagnostics keeps the protocol, implementation and lifecycle record aligned. Stratification, regression, propensity scores, weighting or matching adjust measured differences. Balance, positivity, extreme weights and model specification are examined. No technique removes unmeasured confounding merely because software produces an estimate. Remember: A protocol written after results are known cannot provide the same protection against outcome-driven choices.
Try this
Audit the lifecycle record for confounding methods require overlap and diagnostics. Reproduce confounding methods require overlap and diagnostics from versioned data, code, cohort flow and decision logs. Mark what changed, why it changed and what evidence closed the question. Preserve this caution: A protocol written after results are known cannot provide the same protection against outcome-driven choices.
A strong science note separates observation from interpretation. Reproduce confounding methods require overlap and diagnostics from versioned data, code, cohort flow and decision logs. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Reproduce confounding methods require overlap and diagnostics from versioned data, code, cohort flow and decision logs. Keep this boundary visible: A protocol written after results are known cannot provide the same protection against outcome-driven choices.
CHAPTER 13 OF 17 · Report a reproducible answer
13. Missing data need a mechanism and sensitivity plan
Absence can mean no event, no test, care outside the system or failed capture. Complete-case analysis, imputation or missing categories rest on assumptions. Sensitivity analyses show how conclusions change under plausible departures.
The scientific value of missing data need a mechanism and sensitivity plan appears when evidence is connected to a defined decision. Absence can mean no event, no test, care outside the system or failed capture. Complete-case analysis, imputation or missing categories rest on assumptions. Sensitivity analyses show how conclusions change under plausible departures. Keep this boundary visible: Real-world data record healthcare processes as well as health, and those processes can change over time.
Try this
Build an evidence map for missing data need a mechanism and sensitivity plan. Write the population, exposure, comparator, outcome and time frame for missing data need a mechanism and sensitivity plan before inspecting results. Add the decision, owner and acceptance criterion. Keep this limit: Real-world data record healthcare processes as well as health, and those processes can change over time.
A strong science note separates observation from interpretation. Write the population, exposure, comparator, outcome and time frame for missing data need a mechanism and sensitivity plan before inspecting results. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Write the population, exposure, comparator, outcome and time frame for missing data need a mechanism and sensitivity plan before inspecting results. Keep this boundary visible: Real-world data record healthcare processes as well as health, and those processes can change over time.
CHAPTER 14 OF 17 · Report a reproducible answer
14. Measurement error can affect exposure, outcome and covariates
Misclassification may be differential or nondifferential and can bias results in several directions. Validation subsets, probabilistic bias analysis, alternative definitions and negative controls can illuminate robustness.
For measurement error can affect exposure, outcome and covariates, a useful explanation shows the data, assumptions and operational response together. Misclassification may be differential or nondifferential and can bias results in several directions. Validation subsets, probabilistic bias analysis, alternative definitions and negative controls can illuminate robustness. Preserve this guardrail: Adjustment controls measured confounders only to the extent that variables are valid and models have support.
Try this
Challenge the assumptions behind measurement error can affect exposure, outcome and covariates. Trace every variable in measurement error can affect exposure, outcome and covariates to its operational source and validation evidence. Test a plausible failure mode and record the result. Respect this boundary: Adjustment controls measured confounders only to the extent that variables are valid and models have support.
A strong science note separates observation from interpretation. Trace every variable in measurement error can affect exposure, outcome and covariates to its operational source and validation evidence. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Trace every variable in measurement error can affect exposure, outcome and covariates to its operational source and validation evidence. Keep this boundary visible: Adjustment controls measured confounders only to the extent that variables are valid and models have support.
CHAPTER 15 OF 17 · Report a reproducible answer
15. The analysis plan should precede outcome-driven choices
Cohort construction, code lists, models, censoring, subgroups, multiplicity and sensitivity analyses are prespecified. Revisions are timestamped with reasons and whether results were known. Reproducible code and versioned data preserve the actual execution.
A trustworthy account of the analysis plan should precede outcome-driven choices keeps the protocol, implementation and lifecycle record aligned. Cohort construction, code lists, models, censoring, subgroups, multiplicity and sensitivity analyses are prespecified. Revisions are timestamped with reasons and whether results were known. Reproducible code and versioned data preserve the actual execution. Remember: A diagnosis code can be a useful signal without being a perfectly timed or confirmed clinical event.
Try this
Audit the lifecycle record for the analysis plan should precede outcome-driven choices. Challenge the analysis plan should precede outcome-driven choices with a negative control, alternate definition or quantitative bias analysis. Mark what changed, why it changed and what evidence closed the question. Preserve this caution: A diagnosis code can be a useful signal without being a perfectly timed or confirmed clinical event.
A strong science note separates observation from interpretation. Challenge the analysis plan should precede outcome-driven choices with a negative control, alternate definition or quantitative bias analysis. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Challenge the analysis plan should precede outcome-driven choices with a negative control, alternate definition or quantitative bias analysis. Keep this boundary visible: A diagnosis code can be a useful signal without being a perfectly timed or confirmed clinical event.
CHAPTER 16 OF 17 · Report a reproducible answer
16. Sensitivity analyses test rival explanations
Alternative exposure gaps, lag periods, outcome definitions, comparators, confounding methods, negative controls and quantitative bias analyses challenge the primary result. A long list of nearly identical models is less useful than tests of the assumptions most likely to fail.
The scientific value of sensitivity analyses test rival explanations appears when evidence is connected to a defined decision. Alternative exposure gaps, lag periods, outcome definitions, comparators, confounding methods, negative controls and quantitative bias analyses challenge the primary result. A long list of nearly identical models is less useful than tests of the assumptions most likely to fail. Keep this boundary visible: A protocol written after results are known cannot provide the same protection against outcome-driven choices.
Try this
Build an evidence map for sensitivity analyses test rival explanations. Reproduce sensitivity analyses test rival explanations from versioned data, code, cohort flow and decision logs. Add the decision, owner and acceptance criterion. Keep this limit: A protocol written after results are known cannot provide the same protection against outcome-driven choices.
A strong science note separates observation from interpretation. Reproduce sensitivity analyses test rival explanations from versioned data, code, cohort flow and decision logs. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Reproduce sensitivity analyses test rival explanations from versioned data, code, cohort flow and decision logs. Keep this boundary visible: A protocol written after results are known cannot provide the same protection against outcome-driven choices.
CHAPTER 17 OF 17 · Report a reproducible answer
17. A complete M14 receipt makes the study auditable
The record includes question, protocol, target population, data sources and dates, provenance, linkage, code lists, exposure and outcome validation, covariates, design, cohort flow, missingness, confounding method, diagnostics, software, code, sensitivity results, limitations, reporting tables and regulatory submission files.
For a complete m14 receipt makes the study auditable, a useful explanation shows the data, assumptions and operational response together. The record includes question, protocol, target population, data sources and dates, provenance, linkage, code lists, exposure and outcome validation, covariates, design, cohort flow, missingness, confounding method, diagnostics, software, code, sensitivity results, limitations, reporting tables and regulatory submission files. Preserve this guardrail: Real-world data record healthcare processes as well as health, and those processes can change over time.
Try this
Challenge the assumptions behind a complete m14 receipt makes the study auditable. Write the population, exposure, comparator, outcome and time frame for a complete m14 receipt makes the study auditable before inspecting results. Test a plausible failure mode and record the result. Respect this boundary: Real-world data record healthcare processes as well as health, and those processes can change over time.
A strong science note separates observation from interpretation. Write the population, exposure, comparator, outcome and time frame for a complete m14 receipt makes the study auditable before inspecting results. Record the source, version or date, population or device context, method, result and one uncertainty. If the official record does not show a field, write “not shown” instead of filling the gap from memory.
Evidence checkpoint
Write the population, exposure, comparator, outcome and time frame for a complete m14 receipt makes the study auditable before inspecting results. Keep this boundary visible: Real-world data record healthcare processes as well as health, and those processes can change over time.
M14 real-world-study map
| Question | Evidence to capture | Boundary to retain |
|---|---|---|
| What is the question? | Population, exposure, comparator, outcome and time | Prespecify purpose |
| Are data fit? | Coverage, provenance, linkage and validation | Assess per question |
| Can bias be reduced? | Design, confounding, missingness and measurement | Test assumptions |
| Can others inspect it? | Protocol, code, diagnostics and reporting | Preserve reproducibility |
Science learning becomes useful when a student can show where a claim came from, why it applies and where it stops. Continue with the eduKate Science Learning Hub, compare choices in the Education Hub, and connect these habits to career pathways built from subject capabilities.
M14 makes real-world evidence hopeful and disciplined at the same time. Everyday healthcare can teach us about medicine safety at enormous scale, provided researchers keep the data-generating system, bias controls, uncertainty and limits as visible as the final estimate.
Primary sources and verification date
Source status checked 26 October 2026. FDA guidance describes the agency’s current thinking and does not replace applicable statutes, regulations or product-specific communication with FDA.
- FDA: ICH M14 Non-Interventional Studies Using Real-World Data — Final Level 1 Guidance, March 2026.
- FDA: Real-World Evidence Overview — Current FDA definitions and programme context.
- FDA: Considerations for Use of RWD and RWE — FDA drug and biological-product decision context.
